Key Takeaways -
Courts Revisit the Constitutionality of the FCA: Recent federal decisions reflect renewed judicial scrutiny of the False Claims Act’s qui tam provisions, which authorize private individuals to bring...more
Key Takeaways:
Major Financial and Operational Impact: On Nov. 5, 2025, CMS finalized a rule that fundamentally changes Medicare payment methodology for a broad range of skin substitute products used for wound care....more
Key Takeaways -
New DOJ Civil Division Branch Established: The Department of Justice (DOJ) announced last month the creation of a new office within the Civil Division focusing on matters under the consumer protection and...more
10/13/2025
/ Consumer Product Safety Commission (CPSC) ,
Consumer Protection Laws ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
Pharmaceutical Industry ,
Public Health